clinical trial · NCT05919563
LTFU Study of Subjects Who Received GRNOPC1
Spinal Cord InjuriesMagnetic Resonance Imaging (MRI)
brief summary
This is a LTFU study for thoracic SCI subjects that were administered GRNOPC1 cells in the main study CP35A007.
started
Oct 6, 2011
primary completion
Dec 12, 2026
completion
Dec 12, 2026
last updated
Aug 21, 2024
detailed description
Study CP35A008 is a Phase 1, multi-center long term follow-up (LTFU) study for five (5) subjects with complete thoracic SCI that were administered 2 million GRNOPC1 cells in the main study CP35A007. The purpose of this study is to monitor long-term safety in subjects for 15 years post GRNOPC1 administration.
official title
Long Term Follow-up of Subjects Who Received GRNOPC1
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol